跳至主要内容
临床试验/NCT02941068
NCT02941068已完成2 期

Prophylactic Annti-fungal Treatment in Severe Sepsis Patients With Perforations in SICU

Nanjing PLA General Hospital0 个研究点目标入组 223 人开始时间: 2012年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
223
主要终点
all cause mortality

研究概览

简要总结

This prospective intended to observe the influence of prophylactic and empirical anti-fungal treatment on Severe Sepsis patients with perforations. With the consent of patients' legal guardian for prophylactic use of antifungal agents, patients were divided into two groups: prophylactic group and Empirical group.

详细描述

Intra-abdominal perforation is the high risk of fungal infection. The flora in digestive tract would colonize and go to the blood to develop severe bacteria and fungal infection in intra-abdominal perforation and about one-third of patients with gastrointestinal perforations or anastomotic leakages in ICU develop intra-abdominal fungal infection. In particular, the severe sepsis arisen from these infections could further increase the mortality. However, empiric/preemptive treatment in most studies failed to improve the prognosis and few of the studies that addressed the influence of prophylactic anti-fungal treatment in patients with GI Perforation.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age ≥16 years
  • the time between gastrointestinal perforations or anastopmotic leakage(s) after abdominal surgery and entering ICU within 6 hours
  • ICU stay of at least 5 days
  • APACHE Ⅱ score within 24 hours of randomization of 16 or more
  • severe sepsis
  • written informed consent -

排除标准

  • documented fungus before gastrointestinal perforations/anastopmotic leakage(s) ongoing antifungal treatment before the study;
  • fluconazole/caspofungin allergy;
  • pregnant of lactating woman;
  • life expectancy of 48 hours or less. -

研究组 & 干预措施

Prophylactic group

Experimental

Patients would received intravenous fluconazole (loading dose 800 mg, then 400 mg/day) or caspofungin (loading dose 70 mg, then 50 mg/day) if patients had organ failure or renal or liver dysfunction during the immediately surgery. The antifungal treatment would continue for 5 to 7 days.

干预措施: fluconazole and caspofungin (Drug)

结局指标

主要结局

all cause mortality

时间窗: six months

次要结局

  • fungal infection(six months)

研究者

发起方
Nanjing PLA General Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Gao Tao

Clinical Professor

Nanjing PLA General Hospital

相似试验